Global Ligand Binding Assay Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Ligand Binding Assay Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Ligand binding assays (LBA) are analytical procedures to quantify an analyte (macromolecule) based on its affinity for a ligand, including but not limited to antibodies, antigens, receptors, oligonucleotides and peptides.
Ligand Binding Assay report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ligand Binding Assay market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biomedical Research and Drug Discovery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ligand Binding Assay industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Ligand Binding Assay key companies include Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc, PerkinElmer Inc, Charles River, Alliance Pharma, Eurofins Discovery, Creative Biogene and IBR Inc, etc. Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc are top 3 players and held % share in total in 2022.
Ligand Binding Assay can be divided into Radioactive and Non-radioactive, etc. Radioactive is the mainstream product in the market, accounting for % share globally in 2022.
Ligand Binding Assay is widely used in various fields, such as Biomedical Research, Drug Discovery and Others,, etc. Biomedical Research provides greatest supports to the Ligand Binding Assay industry development. In 2022, global % share of Ligand Binding Assay went into Biomedical Research filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Ligand Binding Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Sygnature Discovery
Shanghai Medicilon Inc
Intertek Group plc
PerkinElmer Inc
Charles River
Alliance Pharma
Eurofins Discovery
Creative Biogene
IBR Inc
LGC Limited
Accelero Bioanalytics GmbH
Gifford Bioscience Limited
GE Healthcare
Antigen Discovery Inc
Segment by Type
Radioactive
Non-radioactive
Biomedical Research
Drug Discovery
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ligand Binding Assay market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Ligand Binding Assay introduction, etc. Ligand Binding Assay Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Ligand Binding Assay market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Ligand Binding Assay report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ligand Binding Assay market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biomedical Research and Drug Discovery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ligand Binding Assay industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Ligand Binding Assay key companies include Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc, PerkinElmer Inc, Charles River, Alliance Pharma, Eurofins Discovery, Creative Biogene and IBR Inc, etc. Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc are top 3 players and held % share in total in 2022.
Ligand Binding Assay can be divided into Radioactive and Non-radioactive, etc. Radioactive is the mainstream product in the market, accounting for % share globally in 2022.
Ligand Binding Assay is widely used in various fields, such as Biomedical Research, Drug Discovery and Others,, etc. Biomedical Research provides greatest supports to the Ligand Binding Assay industry development. In 2022, global % share of Ligand Binding Assay went into Biomedical Research filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Ligand Binding Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Sygnature Discovery
Shanghai Medicilon Inc
Intertek Group plc
PerkinElmer Inc
Charles River
Alliance Pharma
Eurofins Discovery
Creative Biogene
IBR Inc
LGC Limited
Accelero Bioanalytics GmbH
Gifford Bioscience Limited
GE Healthcare
Antigen Discovery Inc
Segment by Type
Radioactive
Non-radioactive
Segment by Application
Biomedical Research
Drug Discovery
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ligand Binding Assay market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Ligand Binding Assay introduction, etc. Ligand Binding Assay Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Ligand Binding Assay market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.